Company Filing History:
4 out of 915 
2 out of 1,289 
Years Active: 2014-2024
Title: Ernst Lengyel: Innovator in Cancer Treatment
Introduction
Ernst Lengyel is a prominent inventor based in Chicago, IL (US), known for his significant contributions to cancer treatment. With a total of 4 patents, he has focused on developing innovative therapies that target specific cancer antigens.
Latest Patents
One of his latest patents involves methods of treating cancers with CT45 targeted therapies. This disclosure relates to treating ovarian cancer based on the specific antigen expression of the cancer. The expressed antigen can be utilized in immunotherapeutic methods for the treatment of ovarian cancer. Aspects of this patent include immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.
Career Highlights
Throughout his career, Ernst Lengyel has worked with esteemed institutions such as the University of Chicago and the Max Planck Society for the Advancement of Science. His work has significantly impacted the field of cancer research and treatment.
Collaborations
He has collaborated with notable colleagues, including Matthias Mann and Marion Curtis, further enhancing the scope and impact of his research.
Conclusion
Ernst Lengyel's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His contributions continue to pave the way for new therapeutic approaches in oncology.